Ptelatoside B exhibits significant anti-inflammatory activity by inhibiting key pro-inflammatory mediators such as nitric oxide and cytokines in cellular models. It has been studied for its potential in managing chronic inflammatory conditions due to its ability to suppress NF-κB signaling, a central pathway in inflammation regulation. Additionally, preliminary research suggests it may possess cytotoxic properties against certain cancer cell lines, indicating possible utility in oncology drug development. Its natural origin and structural complexity also make it a candidate for use in phytochemical profiling and chemotaxonomic studies of plant species.